Astellas Pharma Inc (ALPMY)
9.872
-0.21
(-2.06%)
USD |
OTCM |
Dec 16, 15:37
Astellas Pharma Price to Book Value: 1.650 for Dec. 16, 2024
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.8698 |
| Pfizer Inc | 1.551 |
| Nxera Pharma Co Ltd | 1.458 |
| PeptiDream Inc | 6.087 |
| Healios KK | 6.036 |
Price to Book Value Related Metrics
| PE Ratio | 169.28 |
| PS Ratio | 1.558 |
| Price | 9.872 |
| Earnings Yield | 0.59% |
| Market Cap | 17.67B |
| Operating PE Ratio | 172.44 |
| Normalized PE Ratio | 362.16 |